- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03493555
Optimizing PrEP Adherence for Young Men Who Have Sex With Men
Optimizing PrEP Adherence for YMSM Through the Exploration of Facilitators and Barriers and by the Provision of a Culturally-Tailored Peer Navigation Program
The specific aims of this study are:
- To explore perceived facilitators and barriers to initiating and adhering to HIV PRE-EXPOSURE PROPHYLAXIS (PrEP) among at-risk YOUNG MEN WHO HAVE SEX WITH MEN (YMSM).
- To assess the acceptability and feasibility of a culturally-tailored peer navigator program to optimize adherence to PrEP among YMSM.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
New HIV infections occur at a disproportionately high rate among young men who have sex with men (YMSM).Oral pre-exposure prophylaxis (PrEP) can reduce HIV acquisition among MSM over 90% when adherence levels are high, and increasing the effective use of PrEP among YMSM is one of the highest priorities in HIV prevention. However, YMSM face multiple barriers to initiating and adhering to PrEP, including structural barriers (e.g. housing insecurity), psychosocial factors (e.g. substance use, depression), underestimation of their risk for acquiring HIV, and ambivalence about using PrEP due to medical mistrust. In an open-label study of PrEP use by 200 YMSM, only one-third of participants had protective levels of drug in their blood at 1 year despite intensive adherence counseling, and HIV incidence was high at 3% per year. When PrEP is prescribed to YMSM in care settings, where adherence support is less intensive than in clinical studies, adherence levels, and thus effectiveness, are likely to be even lower. Without strategies to optimize adherence to PrEP for these youth, PrEP is unlikely to have a major impact on HIV incidence for YMSM.
One approach to overcoming the multi-factorial barriers that prevent YMSM from adhering to PrEP is the use of peer health system navigators. Navigators are healthcare workers who are trained to support adherence and retention in care for individuals who are at risk for suboptimal adherence. For YMSM who use PrEP, peer navigators could support adherence by connecting youth with resources to address their unmet structural and psychosocial needs and by helping them to negotiate the complexities of healthcare systems. An NICHD-funded study conducted in Boston (SMILE: Strategic Multisite Initiative for the Identification, Linkage and Engagement in Care of Youth with Undiagnosed HIV) found that peer navigation was highly acceptable for newly diagnosed HIV-infected youth, so it is likely that YMSM will find peer navigation to be acceptable for PrEP. As navigators have been used for over a decade to improve adherence in HIV-infected persons, and an evaluation showed that HIV-infected persons who used navigators had higher rates of virologic suppression, it is important to test whether peer navigation can optimize adherence to PrEP for YMSM.
Our long-term goal is to optimize adherence to PrEP for YMSM and thus decrease HIV incidence. The objective of this study, the first step towards our goal, is to develop and pilot test a peer navigator program to optimize adherence to PrEP for YMSM. We will recruit at-risk YMSM from an LGBTQ Youth-focused community health center with PrEP expertise, the Sidney Borum Jr. Health Center. The Borum Center provides care to 1200 YMSM aged 12-29 annually, half of whom are Black or Latino and 20% of whom are homeless. As incidence rates for HIV (2%) and syphilis (9%) in 2015 were over 20 and 100-fold higher at this center than in the general Boston population, and its clinicians initiate PrEP for 3-4 YMSM monthly, the Borum Center is an ideal setting to explore adherence to PrEP among the highest risk YMSM. Our specific aims are:
Aim 1. To explore perceived facilitators and barriers to initiating and adhering to PrEP among at-risk YMSM. We will conduct in-depth qualitative interviews with 32 YMSM at the Borum Center, including 8 youth who have not yet discussed PrEP with clinicians, 8 who have declined PrEP when offered by clinicians, 8 who have been adherent to PrEP, and 8 with suboptimal adherence. Discussions will include in-depth exploration of YMSM attitudes and intentions regarding PrEP and PrEP peer navigators. We will use purposive sampling to recruit a diverse sample with respect to race, ethnicity, and age, including youth who are minors.
Aim 2. To assess the acceptability and feasibility of a culturally-tailored peer navigator program to optimize adherence to PrEP among YMSM. A PrEP peer navigator program will be adapted from the SMILE study and will be informed by our findings from Aim 1. We will pilot test the program for acceptability and feasibility with 15 YMSM who are newly initiating PrEP at the Borum Center. Secondary outcomes include retention in PrEP care and adherence to PrEP, as measured by dried blood spot testing, at 3 and 6 months.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02215
- The Fenway Institute
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Ages 15-24
- Self-identify as men who have sex with men
- Self-identify as sexually active
- Able to understand English
Exclusion Criteria:
- None
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention Development
Peer Health Navigator for PrEP
|
Peer health systems navigator to improve adherence to PrEP
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Peer Navigation for PrEP Acceptability and Feasibility
Time Frame: up to 6 months post-enrollment
|
For the primary outcome, the investigators will conduct qualitative interviews (using an IRB-approved semi-structured interview guide) at 3 and 6 months post-enrollment.
Additionally, a question about acceptability of the intervention will be asked at 3 and 6 months post-enrollment.
An affirmative response rate of 70% or higher will indicate acceptability of the intervention.
|
up to 6 months post-enrollment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
PrEP Adherence Through DBS
Time Frame: up to 6 months post-enrollment
|
For the secondary outcome, the investigators will use dried blood spot testing (DBS) to measure participants' PrEP drug levels.
|
up to 6 months post-enrollment
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 938125
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pre-Exposure Prophylaxis
-
Penn State UniversityCompleted
-
Anupama Raghuram MDGilead Sciences; University of LouisvilleNot yet recruiting
-
University of GeorgiaNational Institute of Mental Health (NIMH)Not yet recruitingHIV Pre-exposure ProphylaxisUnited States
-
Duke UniversityGilead SciencesRecruitingHIV Prevention | HIV Pre-exposure Prophylaxis | HIV Prevention Program | HIV Prevention and Care | HIV Pre-exposure Prophylaxis UseUnited States
-
Massachusetts General HospitalBrigham and Women's HospitalNot yet recruitingHIV Pre-exposure Prophylaxis UseUnited States
-
University of MichiganNational Institute of Mental Health (NIMH)Enrolling by invitationHIV Prevention | Pre-Exposure Prophylaxis (PrEP)United States
-
University of Illinois at ChicagoNational Institute of Nursing Research (NINR)Active, not recruitingSex Work | Pre-Exposure ProphylaxisUnited States
-
Medstar Health Research InstituteCompletedPre-Exposure ProphylaxisUnited States
-
Indiana UniversityCompletedPre-Exposure ProphylaxisUnited States
-
George Washington UniversityNational Institute of Allergy and Infectious Diseases (NIAID); Gilead SciencesCompletedPre-Exposure ProphylaxisUnited States
Clinical Trials on Peer Health Navigator for PrEP
-
Illinois Institute of TechnologyPatient-Centered Outcomes Research Institute; TrilogyCompletedMental DisordersUnited States
-
Montefiore Medical CenterNational Institute of Mental Health (NIMH); Albert Einstein College of Medicine and other collaboratorsCompletedHIV Prevention | PrEP UptakeUnited States
-
Washington State UniversityNational Institute of Mental Health (NIMH)Recruiting
-
University of California, Los AngelesLos Angeles County Department of Public HealthCompletedHIV-infection/AidsUnited States
-
University of California, Los AngelesCompleted
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development...Active, not recruiting
-
University of Illinois at ChicagoShirley Ryan AbilityLab; Oakland University; Access LivingActive, not recruiting
-
CrescentCareRecruiting
-
University of California, Los AngelesNot yet recruiting
-
Indiana UniversityAcademic Model Providing Access to Healthcare (AMPATH); Indiana CTSICompletedStigma, Social | HIV Pre-exposure ProphylaxisKenya